ELUTIA INC. ELUT
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-08
ELUTIA INC. statistics & valuation
Market cap$44.2M
P / E0.8×
P / S3.6×
P / B1.6×
Net margin434.2%
Return on equity192.9%
FCF margin-379.8%
Return on capital-72.3%
Graham number +319.8%$3.43
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($3.43); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Gross margin | 53.7% | 46.4% | 44.7% | 48.8% | 40.1% | 48.2% | 46.1% |
| Operating margin | -218.9% | -212.3% | -123.4% | -147.5% | -48.6% | -31.9% | -19.6% |
| Net margin | 434.2% | -372.9% | -152.2% | -137.9% | -52.4% | -51.1% | -27.8% |
| FCF margin | -379.8% | -161.1% | -89.3% | -92.1% | -33.4% | -33.4% | -18.2% |
| Return on assets | 85.6% | -149.3% | -86.7% | -47.8% | -37.0% | -26.4% | -26.7% |
| Return on equity | 192.9% | 116.6% | 97.6% | 653.6% | -183.7% | -104.8% | 21.7% |
| Debt / equity | — | -0.52× | -0.61× | -4.82× | 1.37× | 1.16× | -0.39× |
| Current ratio | 2.22 | 0.69 | 0.73 | 1.19 | 1.82 | 2.23 | 1.01 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.